ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Bioqual Inc (PK)

Bioqual Inc (PK) (BIOQ)

67,50
0,00
(0,00%)
Fermé 22 Septembre 10:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
67,50
Prix Achat
66,60
Prix Vente
69,52
Volume échangé
-
0,00 Fourchette du Jour 0,00
59,00 Plage de 52 semaines 80,00
Cap du marché
Clôture Veille
67,50
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
334
Actions en circulation
894 416
Rendement du Dividende
0.74%
Ratio Cours sur Bénéfices
72,30
Bénéfice par action (BPA)
0,93
Chiffre d'affairess
62,66M
Bénéfice net
835k

À propos de Bioqual Inc (PK)

BIOQUAL, Inc. is committed to providing quality research, model development, pre-clinical, testing/assay, and consulting services to commercial clients and Government laboratories. BIOQUAL, Inc. is committed to providing quality research, model development, pre-clinical, testing/assay, and consulting services to commercial clients and Government laboratories.

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Bioqual Inc (PK) est coté dans le secteur Coml Physical, Biologcl Resh de la OTCMarkets avec le ticker BIOQ. Le dernier cours de clôture d'Bioqual (PK) était de US$67,50. Au cours de la dernière année, les actions de Bioqual (PK) ont été négociées dans une fourchette de prix de US$ 59,00 à US$ 80,00.

Bioqual (PK) compte actuellement 894 416 actions en circulation. La capitalisation boursière d'Bioqual (PK) est de US$60,37 million. Bioqual (PK) a un ratio cours/bénéfice (ratio PE) de 72.30.

BIOQ Dernières nouvelles

BIOQUAL Presents Financial Results for Fiscal Year 2014 and Declares Dividend

BIOQUAL:         2014 2013 Revenue $ 21,579,740 $ 20,204,308...

BIOQUAL, Inc., Announces Completion of the Purchase of ABL’s In-Vivo Animal Model Services Related Assets by BIOQUAL & Entr...

BIOQUAL, Inc. (BIOQUAL), announced today that it has completed its acquisition of ABL, Inc.’s (ABL) in-vivo animal model services-related assets. BIOQUAL and ABL will jointly market...

BIOQUAL & ABL, Inc. Announce Agreement for the Sale of ABL’s In-Vivo Animal Model Services Related Assets to BIOQUAL & Stra...

ABL, Inc. (ABL), and BIOQUAL, Inc. (BIOQUAL) announced today that they have signed a definitive agreement for BIOQUAL to acquire in-vivo animal model services-related assets from ABL. The...

BIOQUAL Presents Financial Results for Fiscal Year 2013

BIOQUAL, Inc. (Pinksheets: BIOQ):     2013 2012 Revenue $ 20,204,308 $ 22,667,149...

BIOQUAL Announces the Retirement of John C. Landon as Chief Executive Officer of BIOQUAL & the Appointment of Mark G. Lewis, ...

Dr. John C. Landon founded BIOQUAL in 1982. He led BIOQUAL for more than 30 years as President and Chief Executive Officer, and grew BIOQUAL to its current position as a $20M+ life sciences...

BIOQUAL Presents Financial Results for Fiscal Year 2012 and Declares Dividend

BIOQUAL (Pinksheets: BIOQ):     2012 2011   Revenue $ 22,667,149...

BIOQUAL Announces That the National Cancer Institute Will Not Exercise the Final Option for a Mouse Breeding Facility

BIOQUAL (Pinksheets: BIOQ) has received notice from the National Cancer Institute (NCI) that the NCI will not be exercising its option to renew the contract “Facility for...

BIOQUAL Names Dr. Mark Lewis President

Dr. Mark Lewis has been promoted to President of BIOQUAL Inc. (Pinksheets: BIOQ) by the Board of Directors effective November 15, 2010. Dr. John Landon will continue as Chief...

BIOQUAL Presents Financial Results for Fiscal Year 2010 and Declares Dividend

BIOQUAL (Pinksheets:BIOQ):           2010 2009...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.5-3.57142857143707067.550067.875CS
4-2.5-3.57142857143707067.538368.15217391CS
12-5-6.8965517241472.572.567.533469.79962547CS
26-9.5-12.3376623377777767.533371.29554222CS
527.512.560805931370.97420174CS
156-17-20.118343195384.5108.55747778.16317146CS
26033.598.529411764734108.53454666.58832746CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GENNGenesis Healthcare Inc (CE)
US$ 0,0011
(109 900,00%)
2,64k
BYOCBeyond Commerce Inc (PK)
US$ 0,0001
(9 900,00%)
32,65M
KLDOKaleido Biosciences Inc (CE)
US$ 0,0001
(9 900,00%)
154
GWHPGlobal Wholehealth Partners Corporation (CE)
US$ 0,0001
(9 900,00%)
19,55k
EGRNFChina Evergrande Group (CE)
US$ 0,0001
(9 900,00%)
3,86k
THCBFTHC Biomed International Limited (CE)
US$ 0,000001
(-100,00%)
100
ANTGFAdvantagewon Oil Corporation (CE)
US$ 0,000001
(-99,99%)
2,46k
GKINGuskin Gold Corporation (CE)
US$ 0,000001
(-99,97%)
1,5k
MOBOMobile Lads Corporation (CE)
US$ 0,000001
(-99,97%)
40k
JUVAFJuva Life Inc (CE)
US$ 0,000001
(-99,95%)
4,35k
IJJPIJJ Corporation (PK)
US$ 0,0006
(100,00%)
305,25M
EPAZEpazz Inc (PK)
US$ 0,0007
(40,00%)
257,54M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,0001
(0,00%)
219,94M
HMBLHUMBL Inc (PK)
US$ 0,0002
(100,00%)
94,6M
RONNRonn Motor Group Inc (PK)
US$ 0,0008
(-20,00%)
88,56M
Aucune Discussion Trouvée
Ajouter une Discussion